Laura Lovett
Also: CarePort launches a new system to rate skilled nursing facilities, and Fertility Focus rolls out a wearable that helps track ovulation.
This addition is expected to help CareDx expand into the medication adherence space.
The company plans to use the new money to grow out its business and sales team.
The company plans to use this M&A to gain a foothold in the Medicare space.
Also: Phil scores $100 million for its prescription refill platform and Synchron rakes in $40 million.
Once a user has taken the assessment they are given a personalized plan.
The deal is expected to close in the second half of 2021 and be worth roughly $4.2 billion.
Customers are able to track their time, distance, speed, running pace and heart data using the device.
Researchers found that patients using the wearables are more llikely to undergo an ablation procedure than those not using the technology.
PharmStars will be launching its 10-week accelerator in the fall.